Abstract:
Objective To investigate the effect of uridine diphosphate ceramide galactosyltransferase 8 (UGT8) on colorectal cancer (CRC) cell growth and migration, elucidate an underlying mechanism, and assess the potential regulatory role of SRY-box transcription factor 9 (SOX9) on UGT8.
Methods UGT8 and SOX9 mRNA expression levels in CRC tissues, and correlation between their expression levels, were analyzed using GEPIA2, UALCAN, and TIMER 2.0 online databases. UGT8 and SOX9 protein expression in CRC and adjacent tissues was detected using immunohistochemistry, and relationships between their expression and clinicopathological characteristics were analyzed. Impact of UGT8 knockdown on CRC cell proliferation was assessed using a CCK-8 assay, and cell migration was evaluated using Transwell and wound healing assays. Western blot was performed to detect expression of epithelial-mesenchymal transition (EMT) markers (E-cadherin and ZEB1). RT-qPCR and Western blot were used to measure UGT8 mRNA and protein expression levels after SOX9 knockdown. The JASPAR online database was used to assess SOX9 potential for binding to the UGT8 promoter.
Results Bioinformatics analyses revealed significantly higher mRNA expression levels of both UGT8 and SOX9 in CRC tissues than in normal tissues. Positive correlation was observed between expression levels. Immunohistochemistry results showed that tumor UGT8 and SOX9 protein levels were significantly higher than those in adjacent tissues. UGT8 protein level was found to correlates with N stage, and SOX9 protein level correlated with T stage. A positive correlation was observed between UGT8 and SOX9 expression levels. Following UGT8 knockdown, cell proliferation capacity was attenuated and cell migration ability was reduced. E-cadherin expression concurrently increased and ZEB1 expression decreased. RT-qPCR and Western blot results showed that SOX9 knockdown significantly reduced UGT8 mRNA and protein levels. The JASPER website predicts that SOX9 will bind to the UGT8 promoter.
Conclusions UGT8 and SOX9 are highly expressed in CRC tissues, and their expression levels correlate with clinicopathological features. UGT8 and SOX9 expression levels display significant positive correlation. Mechanistically, UGT8 promotes CRC cell proliferation and migration by facilitating epithelial-mesenchymal transition (EMT). SOX9 enhances UGT8 mRNA and protein expression and may bind to the UGT8 promoter region.